Amynah Pradhan

3.5k total citations
78 papers, 2.5k citations indexed

About

Amynah Pradhan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Amynah Pradhan has authored 78 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cellular and Molecular Neuroscience, 35 papers in Molecular Biology and 34 papers in Physiology. Recurrent topics in Amynah Pradhan's work include Neuropeptides and Animal Physiology (38 papers), Pain Mechanisms and Treatments (32 papers) and Migraine and Headache Studies (31 papers). Amynah Pradhan is often cited by papers focused on Neuropeptides and Animal Physiology (38 papers), Pain Mechanisms and Treatments (32 papers) and Migraine and Headache Studies (31 papers). Amynah Pradhan collaborates with scholars based in United States, Canada and France. Amynah Pradhan's co-authors include Christopher J. Evans, Monique L. Smith, Andrew Charles, Brigitte L. Kieffer, Claire Gavériaux‐Ruff, Chihiro Nozaki, Zachariah Bertels, Alycia F Tipton, Brigitte Kieffer and Wendy Walwyn and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Amynah Pradhan

76 papers receiving 2.5k citations

Peers

Amynah Pradhan
Milena De Felice United States
Raghavendra Vasudeva United States
Carol J. Milligan United Kingdom
M.J. Perren United Kingdom
Geoffrey N. Woodruff United Kingdom
Milena De Felice United States
Amynah Pradhan
Citations per year, relative to Amynah Pradhan Amynah Pradhan (= 1×) peers Milena De Felice

Countries citing papers authored by Amynah Pradhan

Since Specialization
Citations

This map shows the geographic impact of Amynah Pradhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amynah Pradhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amynah Pradhan more than expected).

Fields of papers citing papers by Amynah Pradhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amynah Pradhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amynah Pradhan. The network helps show where Amynah Pradhan may publish in the future.

Co-authorship network of co-authors of Amynah Pradhan

This figure shows the co-authorship network connecting the top 25 collaborators of Amynah Pradhan. A scholar is included among the top collaborators of Amynah Pradhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amynah Pradhan. Amynah Pradhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deshpande, Nitin, et al.. (2025). Factors Associated With Postoperative Outcomes in Femtosecond Laser-Assisted Cataract Surgery. Cureus. 17(1). e77933–e77933.
2.
Daibani, Amal El, et al.. (2025). Delta opioid receptors: Overlooked outlier or the next big thing. Current Opinion in Pharmacology. 83. 102528–102528. 1 indexed citations
3.
Melani, Christopher, Max J. Gordon, Stefania Pittaluga, et al.. (2024). Abstract PO-008: Phase I/II study of VIP152 (enitociclib), venetoclax, and prednisone (VVIP) in relapsed/refractory (R/R) lymphoid malignancies. Blood Cancer Discovery. 5(3_Supplement). PO–8.
4.
Ashina, Håkan, Debbie L. Hay, Amynah Pradhan, et al.. (2024). Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine. Nature Reviews Neurology. 20(11). 660–670. 22 indexed citations
5.
Dalela, D., Christopher Melani, Stefania Pittaluga, et al.. (2024). A Pilot Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (VIPOR) for Diffuse Large B-Cell Lymphoma Involving the Central Nervous System. Blood. 144(Supplement 1). 1724–1724. 1 indexed citations
6.
Dhaem, Olivia Begasse de, Anne‐Sophie Wattiez, Irene de Boer, et al.. (2023). Bridging the gap between preclinical scientists, clinical researchers, and clinicians: From animal research to clinical practice. Headache The Journal of Head and Face Pain. 63(1). 25–39. 5 indexed citations
7.
Dalela, D., Stefania Pittaluga, Jagan Muppidi, et al.. (2023). IBCL-297 Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL). Clinical Lymphoma Myeloma & Leukemia. 23. S451–S451. 1 indexed citations
8.
Bertels, Zachariah, et al.. (2023). PACAP-PAC1 receptor inhibition is effective in opioid induced hyperalgesia and medication overuse headache models. iScience. 26(2). 105950–105950. 8 indexed citations
9.
Pittaluga, Stefania, Jagan Muppidi, James D. Phelan, et al.. (2021). Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas. Blood. 138(Supplement 1). 4504–4504. 8 indexed citations
10.
Zhang, Pan, Bruce R. Southey, Jonathan V. Sweedler, Amynah Pradhan, & Sandra L. Rodriguez‐Zas. (2021). Enhanced Understanding of Molecular Interactions and Function Underlying Pain Processes Through Networks of Transcript Isoforms, Genes, and Gene Families. SHILAP Revista de lepidopterología. Volume 14. 49–69. 5 indexed citations
11.
Dripps, Isaac, Zachariah Bertels, Alycia F Tipton, et al.. (2020). Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia. Scientific Reports. 10(1). 17629–17629. 15 indexed citations
12.
Shiwarski, Daniel J., Alycia F Tipton, Brigitte F. Schmidt, et al.. (2017). A PTEN-Regulated Checkpoint Controls Surface Delivery of δ Opioid Receptors. Journal of Neuroscience. 37(14). 3741–3752. 36 indexed citations
13.
Vicente‐Sánchez, Ana & Amynah Pradhan. (2017). Ligand-Directed Signaling at the Delta Opioid Receptor. Handbook of experimental pharmacology. 247. 73–85. 7 indexed citations
14.
Cahill, Catherine M., Wendy Walwyn, Anna M.W. Taylor, Amynah Pradhan, & Christopher J. Evans. (2016). Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation. Trends in Pharmacological Sciences. 37(11). 963–976. 86 indexed citations
15.
Charles, Andrew & Amynah Pradhan. (2016). Delta-opioid receptors as targets for migraine therapy. Current Opinion in Neurology. 29(3). 314–319. 30 indexed citations
16.
Vicente‐Sánchez, Ana, Laura Segura, & Amynah Pradhan. (2016). The delta opioid receptor tool box. Neuroscience. 338. 145–159. 28 indexed citations
17.
Taylor, Anna M.W., Annie Castonguay, Atefeh Ghogha, et al.. (2015). Neuroimmune Regulation of GABAergic Neurons Within the Ventral Tegmental Area During Withdrawal from Chronic Morphine. Neuropsychopharmacology. 41(4). 949–959. 89 indexed citations
18.
Pradhan, Amynah, Wendy Walwyn, Chihiro Nozaki, et al.. (2010). Ligand-Directed Trafficking of the δ-Opioid ReceptorIn Vivo: Two Paths Toward Analgesic Tolerance. Journal of Neuroscience. 30(49). 16459–16468. 111 indexed citations
19.
Pradhan, Amynah, Xiao Yu, & Jennifer M.A. Laird. (2009). Modality of hyperalgesia tested, not type of nerve damage, predicts pharmacological sensitivity in rat models of neuropathic pain. European Journal of Pain. 14(5). 503–509. 19 indexed citations
20.
Pradhan, Amynah, Paul Cumming, & Paul B. S. Clarke. (2002). [125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents. Brain Research. 954(2). 227–236. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026